Breakthrough HIV drug sees 18 patent filings, may delay affordable generics
Times of India
A breakthrough HIV drug has seen 18 patent filings, which may delay the availability of affordable generics.
Times of India
A breakthrough HIV drug has seen 18 patent filings, which may delay the availability of affordable generics.
Several outlets reported this. AI can compare where they agree and differ.
Economic Times
Economic Times
Economic Times
WorldEconomic Times
IndiaTimes of India
The Health Ministry has introduced new regulations aimed at suspending manufacturing licenses for medicines that do not meet quality criteria. This swift action is intended to stop subpar drugs from reaching patients and to minimize their circulation during the regulatory review. Licenses can be suspended based on government analysts' findings that indicate deficiencies.
IndiaLiveMint
The Centre plans to upgrade high-performing Jan Aushadhi Kendras into modern flagship outlets with a better drug portfolio, redesigned store layouts and enhanced credit facilities
IndiaTimes of India